TABLE 2.
Alkaline phosphatase activities of cells infected with pseudovirus following neutralization with various concentrations of serum pretreated with wild-type or hybrid VLPs
| Serum | Activity for VLP used to pretreat seraa
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 16wt | 16:BC | 16:DE | 16:EF | 16:FG | 16:FG/HI | 16:410 | 16:430 | 31wt | No capsids | |
| I | + | + | ± | ± | ND | − | + | + | − | − |
| J 2001 | + | ± | + | − | + | ± | ± | + | − | ND |
| K | + | + | − | + | ± | ± | + | + | − | ND |
| L | + | + | + | ± | + | + | + | + | − | ND |
| M | + | + | ± | + | − | − | + | + | − | ND |
| N | + | + | − | ± | ND | ± | + | + | − | − |
| O | + | + | − | ± | ND | − | + | + | − | − |
| P | + | + | − | + | ND | ± | + | + | − | − |
| Q | + | ± | − | + | ND | ± | + | + | − | − |
| R | + | + | − | + | ± | ± | + | + | − | ND |
| S | + | + | ± | + | ± | ± | + | + | − | ND |
| T | + | ± | − | ± | + | ± | + | + | − | ND |
| U | + | + | − | + | ± | ± | + | + | − | ND |
| V | + | ± | − | ± | ± | ± | + | + | − | ND |
| J 1992 | + | + | − | − | − | − | + | + | − | ND |
a
ND, not done; +, normalized optical-density values ≥2/3 of wild-type 16 value; −, normalized optical-density values <1/3 of wild-type 16 value; ±, normalized optical-density values >1/3 but <2/3 of wild-type 16 value.